We are live on ! Find out more
AIC

Argus Investors Counsel Portfolio holdings

AUM $130M
1-Year Est. Return 37.06%
This Fund
S&P 500
This Quarter Est. Return
+12.42%
1 Year Est. Return
+37.06%
3 Year Est. Return
+123.69%
5 Year Est. Return
+149.89%
10 Year Est. Return
+466.25%
AUM
$156M
AUM Growth
+$17M
Cap. Flow
+$1.18M
Cap. Flow %
0.76%
Top 10 Hldgs %
27.12%
Holding
104
New
9
Increased
44
Reduced
36
Closed
6

Top Buys

Rank Stock Value
1
MCK icon
McKesson
MCK
+$875K
2
CRM icon
Salesforce
CRM
+$844K
3
AMZN icon
Amazon
AMZN
+$826K
4
AJG icon
Arthur J. Gallagher & Co
AJG
+$707K
5
ADI icon
Analog Devices
ADI
+$492K

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$991K
2
APD icon
Air Products & Chemicals
APD
+$988K
3
AMT icon
American Tower
AMT
+$619K
4
LLY icon
Eli Lilly
LLY
+$541K
5
MRNA icon
Moderna
MRNA
+$527K

Sector Composition

Rank Sector Weight
1 Technology 24.54%
2 Financials 16.39%
3 Healthcare 13.44%
4 Industrials 12.8%
5 Consumer Discretionary 9.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADM icon
51
Archer Daniels Midland
ADM
$38.6B
$1.47M 0.94%
20,315
+5,100
+34% +$373K
IP icon
52
International Paper
IP
$22.1B
$1.46M 0.94%
40,390
+500
+1% +$17.5K
PG icon
53
Procter & Gamble
PG
$337B
$1.46M 0.94%
9,943
+8
+0.1% +$1.19K
VZ icon
54
Verizon
VZ
$196B
$1.43M 0.92%
37,817
+32
+0.1% +$1.13K
BDX icon
55
Becton Dickinson
BDX
$49.4B
$1.36M 0.87%
5,560
ABT icon
56
Abbott
ABT
$190B
$1.35M 0.87%
12,285
-609
-5% -$60.8K
AMAT icon
57
Applied Materials
AMAT
$417B
$1.34M 0.86%
8,268
+7
+0.1% +$1.03K
DIS icon
58
Walt Disney
DIS
$179B
$1.33M 0.86%
14,760
GLW icon
59
Corning
GLW
$137B
$1.27M 0.82%
41,811
-57
-0.1% -$1.63K
NOC icon
60
Northrop Grumman
NOC
$81.6B
$1.27M 0.82%
2,713
+47
+2% +$22K
PFE icon
61
Pfizer
PFE
$152B
$1.25M 0.8%
43,315
+6,350
+17% +$192K
PYPL icon
62
PayPal
PYPL
$50.5B
$1.18M 0.76%
19,150
+2,350
+14% +$135K
WFC icon
63
Wells Fargo
WFC
$265B
$1.15M 0.74%
23,378
+20
+0.1% +$863
CVX icon
64
Chevron
CVX
$385B
$1.12M 0.72%
7,519
+5
+0.1% +$756
CRM icon
65
Salesforce
CRM
$162B
$982K 0.63%
+3,731
New +$844K
IWF icon
66
iShares Russell 1000 Growth ETF
IWF
$127B
$939K 0.6%
12,388
-416
-3% -$29.4K
MCK icon
67
McKesson
MCK
$105B
$891K 0.57%
+1,925
New +$875K
UNH icon
68
UnitedHealth
UNH
$366B
$875K 0.56%
1,662
+47
+3% +$25.1K
HOLX
69
DELISTED
Hologic
HOLX
$853K 0.55%
11,935
+60
+0.5% +$4.18K
MA icon
70
Mastercard
MA
$493B
$787K 0.51%
1,845
-7
-0.4% -$2.81K
BSV icon
71
Vanguard Short-Term Bond ETF
BSV
$45.6B
$761K 0.49%
9,881
+52
+0.5% +$3.94K
DHR icon
72
Danaher
DHR
$146B
$677K 0.43%
2,925
-240
-8% -$51.1K
AJG icon
73
Arthur J. Gallagher & Co
AJG
$65.5B
$671K 0.43%
+2,983
New +$707K
INTU icon
74
Intuit
INTU
$91.9B
$669K 0.43%
1,070
-28
-3% -$15.4K
LMT icon
75
Lockheed Martin
LMT
$138B
$613K 0.39%
1,352
-22
-2% -$9.75K

Similar funds

Argus Investors Counsel's Q4 2023 Portfolio in Review

As of Q4 2023, Argus Investors Counsel held 104 positions worth $156M, up 12% from $139M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Argus Investors Counsel's Q4 2023 filing shows 9 new, 44 increased, 36 reduced and 6 closed positions. Its largest new stake was McKesson: 1,925 shares worth $891K. The largest sale was Merck, an estimated $991K.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Argus Investors Counsel's largest Q4 2023 buy was McKesson: 1,925 shares worth $891K.
  • Argus Investors Counsel added most to Amazon in Q4 2023, an estimated $826K increase.
  • Argus Investors Counsel's biggest Q4 2023 reduction was Air Products & Chemicals, cutting an estimated $988K.
  • Argus Investors Counsel fully exited Merck in Q4 2023, selling an estimated $991K.
  • Argus Investors Counsel's ten largest holdings make up 27% of its $156M portfolio in Q4 2023.
  • Argus Investors Counsel opened 9 new positions and closed 6 in Q4 2023.
  • Argus Investors Counsel's portfolio value rose 12% quarter-over-quarter to $156M.

Based on Argus Investors Counsel's 13F filing for Q4 2023, filed 22 Jan 2024.